Clinical Trial Update: Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing lapatinib in combination with trastuzumab versus lapatinib alone in HER2-positive metastatic breast cancer completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Tykerb (lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 3 | Status: COMPLETED | Results posted: 2011-11-30